Show simple item record

Multi-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting

dc.contributor.authorOndiek, J
dc.contributor.authorNamukaya, Z
dc.contributor.authorMtapuri-Zinyowera, S
dc.contributor.authorBalkan, S
dc.contributor.authorElbireer, A
dc.contributor.authorUshiro Lumb, I
dc.contributor.authorKiyaga, C
dc.contributor.authorGoel, N
dc.contributor.authorRitchie, A
dc.contributor.authorNcube, P
dc.contributor.authorOmuomu, K
dc.contributor.authorNdiege, K
dc.contributor.authorKekitiinwa, A
dc.contributor.authorMangwanya, D
dc.contributor.authorFowler, Mary G
dc.contributor.authorNadala, L
dc.contributor.authorLee, H
dc.date.accessioned2017-07-05T18:24:55Z
dc.date.available2017-07-05T18:24:55Z
dc.date.issued2017-06-09
dc.date.submitted2017-06-26
dc.identifier.citationMulti-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting. 2017 J. Acquir. Immune Defic. Syndr.en
dc.identifier.issn1944-7884
dc.identifier.pmid28604503
dc.identifier.doi10.1097/QAI.0000000000001476
dc.identifier.urihttp://hdl.handle.net/10144/618951
dc.description.abstractEarly diagnosis of HIV-1 infection and the prompt initiation of antiretroviral therapy are critical to achieving a reduction in the morbidity and mortality of infected infants. The SAMBA HIV-1 Qual Whole Blood Test was developed specifically for early infant diagnosis and prevention of mother-to-child transmission programs implemented at the point-of-care in resource-limited settings.
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen
dc.rightsArchived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999)en
dc.titleMulti-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Settingen
dc.identifier.journalJournal of Acquired Immune Deficiency Syndromes (1999)en
refterms.dateFOA2019-03-04T13:29:04Z
html.description.abstractEarly diagnosis of HIV-1 infection and the prompt initiation of antiretroviral therapy are critical to achieving a reduction in the morbidity and mortality of infected infants. The SAMBA HIV-1 Qual Whole Blood Test was developed specifically for early infant diagnosis and prevention of mother-to-child transmission programs implemented at the point-of-care in resource-limited settings.


Files in this item

Thumbnail
Name:
Ondiek J et al - 2017 - Multi- ...
Size:
434.5Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record